Prognostic scores in primary biliary cholangitis patients with advanced disease

Table 3 Multivariable analyses of risk prediction scores after 1 year of ursodeoxycholic acid therapy

	Univariate analyses			Multivariable analyses
Prognostic score	Hazard ratio	95%CI	P value	Hazard ratio	95%CI	P value
GLOBE	1.703	1.474-1.967	< 0.001	1.582	1.029-2.433	0.037
UK-PBC	6.046	3.479-10.510	< 0.001	1.012	0.330-3.102	0.983
APRI	0.998	0.971-1.024	0.860	0.918	0.812-1.038	0.171
FIB4	1.005	0.997-1.013	0.242	1.008	0.991-1.024	0.369
ALBI	2.546	1.955-3.316	< 0.001	1.194	0.595-2.40	0.618
Mayo	1.495	1.348-1.676	< 0.001	1.022	0.697-1.497	0.913

ALBI: Albumin-bilirubin; APRI: Aspartate aminotransferase-to-platelet ratio index; CI: Confidence interval; FIB4: Fibrosis-4 index.